摘要 |
<p>A therapeutic preparation for the treatment of dermal, labial, intra-oral and gastro-intestinal tract ulcers, corrosive wounds, bed sores, burns, frost-bite and scleroderma contains as a primary ingredient a compound having an aldose reductase inhibitory activity and which can accelerate dermal metabolism. Preferred compounds are optically active hydantoin derivatives.</p> |
申请人 |
SANWA KAGAKU KENKYUSHO CO., LTD. |
发明人 |
SAWAI, KIICHI, C/O SANWA KAGAKU KENKYUSHO CO. LTD.;KURONI, MASAYASU, C/O SANWA KAGAKU KENKYUSHO CO.,;NAKANO, KAZUMASA, C/O SANWA KAGAKU KENKYUSHO CO.,;SATO, MAKOTO, C/O SANWA KAGAKU KENKYUSHO CO., LTD.;KUBOYAMA, NOBORU, C/O SANWA KAGAKU KENKYUSHO CO.;ITO, TAKASHI, C/O SANWA KAGAKU KENKYUSHO CO., LTD.;KONDO, YOSHIYA, C/O SANWA KAGAKU KENKYUSHO CO. |